Tag: Coronary Artery Disease

First-in-human Trial of CRISPR Gene-editing ANGPTL3 Safely Lowered Cholesterol and Triglycerides

Key Points: CTX310 is a first-in-class in vivo CRISPR-Cas9 therapy designed to…

Basir Gill

Tirzepatide Lowers MACE vs Dulaglutide in SURPASS-CVOT Patients With Heart Failure

Key Points In SURPASS-CVOT, tirzepatide was previously shown to be non-inferior to…

Alberto Castro-Molina

PCSK9-inhibitors Do Not Reduce Early Cardiac Allograft Vasculopathy: The CAVIAR Trial

Key Points The CAVIAR trial enrolled recent heart transplant recipients to receive…

Basir Gill

NOAC Monotherapy Non-Inferior to Combination Therapy for Net Adverse Clinical events in AF Patients Post–DES: ADAPT AF-DES Trial

Key Points The ADAPT AF-DES randomized trial compared NOAC monotherapy (apixaban or…

Basir Gill

Prasugrel Might be a Better Choice than Ticagrelor For DAPT after PCI for Patients with Diabetes and MVD: The TUXEDO-2 Trial

Key Points TUXEDO-2 directly compared ticagrelor vs prasugrel based DAPT in 1,800…

Basir Gill

CorCMR: Stress Cardiac MRI Uncovers Hidden Angina and Improves Quality of Life in Patients Without Obstructive Coronary Disease

Key Points: Stress cardiac MRI (CMR) enhanced diagnostic accuracy for patients with…

Basir Gill

CELEBRATE: Early Pre-hospital Subcutaneous Zalunfiban Improves Coronary Patency and Outcomes in STEMI Without Increasing Severe Bleeding

Key Points: Early pre-hospital administration of subcutaneous zalunfiban improved coronary patency and…

Basir Gill

FAVOR IV-QVAS: Angio-FFR–Guided CABG During Valve Surgery Improves Outcomes

Key Points: The FAVOR IV-QVAS trial tested the hypothesis physiology-guided coronary artery…

Basir Gill

VESALIUS-CV: PCSK9-Inhibitor Evolocumab Reduces MACE for Primary Prevention

Key Points: PCSK9-inhibitors – including evolocumab – are highly effective LDL-C–lowering medications…

Basir Gill

Remote Acute Assessment Of Patients With High Cardiovascular Risk Post-Acute Coronary Syndrome (TELE-ACS)

Key Points:   TELE-ACS evaluates the use of telemedicine strategies to reduce hospital…

Leah Kosyakovsky

OPTION –Indobufen is Noninferior to Aspirin After Coronary Drug-Eluting Stent Implantation

Key Points: Indobufen, a platelet aggregation inhibitor, has been shown to be…

Leah Kosyakovsky

RAPCO: Radial artery grafting is superior to both RITA and SVG in patients undergoing CABG

Key Points: Recent guidelines have supported the use of arterial grafts over…

Leah Kosyakovsky

CTS-AMI: Tongxinluo (TXL) improves CV outcomes in acute STEMI

Key Points: Tongxinluo (TXL) is a traditional Chinese medicine with endothelial-protective effects…

Leah Kosyakovsky